Viking Therapeutics, 12340 El Camino Real, San Diego, CA 92130, US

Royalty Pharma Management is a San Diego-based firm that operates at the intersection of science, medicine, and investing. As the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences, they have completed over 80 royalty acquisitions and announced transactions worth $30 billion since their founding. With a global market share of more than 60%, they are the preferred partner for biopharma companies, offering tailored funding solutions and win-win partnerships. Royalty Pharma's unique business model provides investors with a distinctive way to invest in biopharma, offering exposure to the best attributes of the industry without the common challenges. Their commitment to creating value for stakeholders is evident through their funding of innovation across the life sciences ecosystem, while minimizing environmental, social, and governance (ESG) risks. With a strong track record and a focus on accelerating bio-innovation, Royalty Pharma is at the forefront of driving advancements in drug discovery and development.Generated from the website